Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review

Ophthalmology

Volumn 125, Issue 2, 2018, Pages 153-160

  Fung, Simon S M ^a   Jabbour, Samir ^b   Harissi Dagher, Mona ^b   Tan, Reginald R G ^c   Hamel, Patrick ^d   Baig, Kashif ^c   Ali, Asim ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; SILICONE OIL; VANCOMYCIN;

ADD ON THERAPY; ADOLESCENT; AMNION; ANTIBIOTIC THERAPY; BACTERIAL KERATITIS; BEST CORRECTED VISUAL ACUITY; CANADA; CANADIAN; CASE STUDY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL OUTCOME; COHORT ANALYSIS; CONFERENCE PAPER; CORNEA DISEASE; CORNEA NECROSIS; CORNEA TRANSPLANTATION; CORNEAL MELT; DEVICE FAILURE; DEVICE RETENTION; ENDOPHTHALMITIS; EROSION; EYE FIXATION; EYE SURGERY; FOLLOW UP; GLAUCOMA; HUMAN; LIGHT PERCEPTION; LIGHT RELATED PHENOMENA; LUNG TUBERCULOSIS; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; NEWBORN; OBSERVATIONAL STUDY; PARS PLANA VITRECTOMY; PEDIATRIC SURGERY; PERCEPTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTHESIS COMPLICATION; PROSTHESIS IMPLANTATION; RETINA DETACHMENT; RETROPROSTHETIC MEMBRANE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLERAL PATCH GRAFT; TECTONIC GRAFT; VISION; VISUAL IMPAIRMENT; VITREORETINAL SURGERY; ARTIFICIAL ORGAN; CLINICAL TRIAL; CORNEA; FEMALE; INCIDENCE; INFANT; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ARTIFICIAL ORGANS; CANADA; CHILD; CHILD, PRESCHOOL; CORNEA; CORNEAL DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; MALE; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 85028070802     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2017.07.009     Document Type: Conference Paper

References (40)

1. Zerbe, B.L., Belin, M.W., Ciolino, J.B., Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113:10 (2006), 1779.e1–1779.e7.
2. Aldave, A.J., Kamal, K.M., Vo, R.C., Yu, F., The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 116:4 (2009), 640–651.
3. Aldave, A.J., Sangwan, V.S., Basu, S., et al. International results with the Boston type I keratoprosthesis. Ophthalmology 119:8 (2012), 1530–1538.
4. Srikumaran, D., Munoz, B., Aldave, A.J., et al. Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 121:11 (2014), 2159–2164.
5. Traish, A.S., Chodosh, J., Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol 25:5–6 (2010), 239–243.
6. Salvador-Culla, B., Kolovou, P.E., Keratoprosthesis: a review of recent advances in the field. J Funct Biomater, 7(2), 2016, 13.
7. Lee, W.B., Shtein, R.M., Kaufman, S.C., et al. Boston keratoprosthesis: outcomes and complications. A report by the American Academy of Ophthalmology. Ophthalmology 122:7 (2015), 1504–1511.
8. Colby, K.A., Koo, E.B., Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 22:4 (2011), 267–273.
9. Kang, J.J., De La Cruz, J., Cortina, M.S., Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. Cornea 31:12 (2012), 1436–1440.
10. Fadous, R., Levallois-Gignac, S., Vaillancourt, L., et al. The Boston keratoprosthesis type 1 as primary penetrating corneal procedure. Br J Ophthalmol 99:12 (2015), 1664–1668.
11. Chang, H.Y.P., Luo, Z.K., Chodosh, J., et al. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases. Cornea 34:3 (2015), 264–270.
12. Haugsdal, J.M., Goins, K.M., Greiner, M.A., et al. Boston type 1 keratoprosthesis for primary congenital glaucoma. Br J Ophthalmol 100:3 (2016), 328–331.
13. Aquavella, J.V., Gearinger, M.D., Akpek, E.K., McCormick, G.J., Pediatric keratoprosthesis. Ophthalmology 114:5 (2007), 989–994.
14. Klufas, M.A., Colby, K.A., The Boston keratoprosthesis. Int Ophthalmol Clin 50:3 (2010), 161–175.
15. Botelho, P.J., Congdon, N.G., Handa, J.T., Akpek, E.K., Keratoprosthesis in high-risk pediatric corneal transplantation: first 2 cases. Arch Ophthalmol 124:9 (2006), 1356–1357.
16. Dohlman, T., Fernandez, A.A., Lertsuwanroj, B., Ciralsky, J., Boston keratoprosthesis type 1 in the pediatric population. Curr Ophthalmol Rep 4:3 (2016), 124–130.
17. Bradley, J.C., Hernandez, E.G., Schwab, I.R., Mannis, M.J., Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 28:3 (2009), 321–327.
18. Nallasamy, S., Colby, K., Keratoprosthesis: procedure of choice for corneal opacities in children?. Semin Ophthalmol 25:5–6 (2010), 244–248.
19. Greiner, M.A., Li, J.Y., Mannis, M.J., Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 118:8 (2011), 1543–1550.
20. Bakhtiari, P., Chan, C., Welder, J.D., et al. Surgical and visual outcomes of the type I Boston keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. Am J Ophthalmol 153:5 (2012), 967–971.e2.
21. Iyer, G., Srinivasan, B., Gupta, N., Padmanabhan, P., Outcome of Boston keratoprosthesis in a developing country: importance of patient selection, education, and perioperative care. The Indian experience. Asia Pac J Ophthalmol (Phila) 1:4 (2012), 202–207.
22. Rachitskaya, A.V., Moysidis, S.N., Miller, D., et al. Streptococcal endophthalmitis in pediatric keratoprosthesis. Ophthalmology 120:7 (2013), 1506–1507.e1.
23. Chhablani, J., Panchal, B., Das, T., et al. Endophthalmitis in Boston keratoprosthesis: case series and review of literature. Int Ophthalmol 35:5 (2015), 673–678.
24. Brown, C., Rowlands, M., Lee, D., et al. Keratoprosthesis in pediatric keratitis-icthyosiform-deafness syndrome. J AAPOS 20:1 (2016), 73–75.
25. Chew, H.F., Ayres, B.D., Hammersmith, K.M., et al. Boston keratoprosthesis outcomes and complications. Cornea 28:9 (2009), 989–996.
26. Robert, M.-C., Moussally, K., Harissi-Dagher, M., Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 96:6 (2012), 776–780.
27. Davies, E., Chodosh, J., Infections after keratoprosthesis. Curr Opin Ophthalmol 27:4 (2016), 373–377.
28. Singer, T.R., Isenberg, S.J., Apt, L., Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects. Br J Ophthalmol 72:6 (1988), 448–451.
29. Sivaraman, K.R., Hou, J.H., Allemann, N., et al. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston keratoprosthesis. Am J Ophthalmol 155:5 (2013), 814–822.
30. Rudnisky, C.J., Belin, M.W., Todani, A., et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 119:5 (2012), 951–955.
31. Wang, Q., Harissi-Dagher, M., Characteristics and management of patients with Boston type 1 keratoprosthesis explantation—the University of Montreal Hospital Center experience. Am J Ophthalmol 158:6 (2014), 1297–1304.e1.
32. Aravena, C., Bozkurt, T.K., Yu, F., Aldave, A.J., Long-term outcomes of the Boston type I keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea 35:9 (2016), 1156–1164.
33. Akpek, E.K., Harissi-Dagher, M., Petrarca, R., et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 144:2 (2007), 227–231.
34. Hassanaly, S.I., Talajic, J.C., Harissi-Dagher, M., Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol 158:2 (2014), 270–276.e1.
35. Huang, C., O'Hara, M., Mannis, M.J., Primary pediatric keratoplasty: indications and outcomes. Cornea 28:9 (2009), 1003–1008.
36. Yang, L.L., Lambert, S.R., Lynn, M.J., Stulting, R.D., Long-term results of corneal graft survival in infants and children with peters anomaly. Ophthalmology 106:4 (1999), 833–848.
37. Fung, S.S., Ali, A., Mireskandari, K., Pediatric corneal transplantation: where are we heading?. Curr Ophthalmol Rep 5:1 (2017), 23–37.
38. Zaidman, G.W., Flanagan, J.K., Furey, C.C., Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. Am J Ophthalmol 144:1 (2007), 104–108.
39. Ali, A., Elbaz, U., Strungaru, H., Mireskandari, K., Clinical and visual outcomes in patients with Peters anomaly. JAAPOS, 19, 2015, e19.
40. Vanathi, M., Panda, A., Vengayil, S., et al. Pediatric keratoplasty. Surv Ophthalmol 54:2 (2009), 245–271.